UNIPHOS ENT 2022-23 Annual Report Analysis

Fri, 31 Mar

UNIPHOS ENT has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

UNIPHOS ENT Income Statement Analysis

• Operating income during the year rose 20.5% on a year-on-year (YoY) basis.
• The company's operating profit was by NA YoY during the fiscal. Operating profit margins witnessed a growth and down at 194.5% in FY23 as against 255.8% in FY22.
• Depreciation charges increased by 1727.3% increased by 0.0% YoY, respectively.
• Other income declined by 24.5% YoY.
• Net profit for the year declined by 28.2% YoY.
• Net profit margins during the year declined from 4468.4% in FY22 to 2664.8% in FY23.

UNIPHOS ENT Income Statement 2022-23

No. of Mths Year Ending		12 Mar-22*	12 Mar-23*	% Change
Net Sales	Rs m	12	15	20.5%
Other income	Rs m	571	431	-24.5%
Total Revenues	Rs m	583	446	-23.6%
Gross profit	Rs m	-31	-29	NA
Depreciation	Rs m	0	6	1,727.3%
Interest	Rs m	0	0	0.0%
Profit before tax	Rs m	539	396	-26.5%
Tax	Rs m	-7	4	NA
Profit after tax	Rs m	546	392	-28.2%
Gross profit margin	%	-255.8	-194.5
Effective tax rate	%	-1.2	1.0
Net profit margin	%	4,468.4	2,664.8

Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...

UNIPHOS ENT Balance Sheet Analysis

• The company's current liabilities during FY23 stood at Rs 11 million as compared to Rs 6 million in FY22, thereby witnessing an increase of 77.0%.
• Current assets fell 11% and stood at Rs 532 million, while fixed assets fell 6% and stood at Rs 30 billion in FY23.
• Overall, the total assets and liabilities for FY23 stood at Rs 31 billion as against Rs 33 billion during FY22, thereby witnessing a fall of 6%.

UNIPHOS ENT Balance Sheet as on March 2023

No. of Mths Year Ending		12 Mar-22*	12 Mar-23*	% Change
Networth	Rs m	31,805	29,976	-5.8
Current Liabilities	Rs m	6	11	77.0
Long-term Debt	Rs m	0	0	0.0
Total Liabilities	Rs m	33,016	30,955	-6.2
Current assets	Rs m	597	532	-10.9
Fixed Assets	Rs m	32,419	30,423	-6.2
Total Assets	Rs m	33,016	30,955	-6.2

UNIPHOS ENT Cash Flow Statement Analysis

• UNIPHOS ENT's cash flow from operating activities (CFO) during FY23 stood at Rs -15 million on a YoY basis.
• Cash flow from investing activities (CFI) during FY23 stood at Rs 406 million, an improvement of 98.8% on a YoY basis.
• Cash flow from financial activities (CFF) during FY23 stood at Rs -393 million on a YoY basis.
• Overall, net cash flows for the company during FY23 stood at Rs -1 million from the Rs -27 million net cash flows seen during FY22.

UNIPHOS ENT Cash Flow Statement 2022-23

Particulars	No. of months	12	12	% Change
	Year Ending	Mar-22	Mar-23
Cash Flow from Operating Activities	Rs m	5	-15	-
Cash Flow from Investing Activities	Rs m	204	406	98.8%
Cash Flow from Financing Activities	Rs m	-236	-393	-
Net Cash Flow	Rs m	-27	-1	-

Current Valuations for UNIPHOS ENT

• The trailing twelve-month earnings per share (EPS) of the company stands at Rs 5.6, an decline from the EPS of Rs 7.9 recorded last year.
• The price to earnings (P/E) ratio, at the current price of Rs 153.9, stands at 27.3 times its trailing twelve months earnings.
• The price to book value (P/BV) ratio at current price levels stands at 0.4 times, while the price to sales ratio stands at 727.2 times.
• The company's price to cash flow (P/CF) ratio stood at 25.4 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending		12 Mar-22*	12 Mar-23*
Sales per share (Unadj.)	Rs	0.2	0.2
TTM Earnings per share	Rs	7.9	5.6
Diluted earnings per share	Rs	7.9	5.6
Price to Cash Flow	x	16.8	25.4
TTM P/E ratio	x	16.9	27.3
Price / Book Value ratio	x	0.3	0.3
Market Cap	Rs m	7,998	10,121
Dividends per share (Unadj.)	Rs	5.7	6.5

Ratio Analysis for UNIPHOS ENT

• Solvency Ratios

Current Ratio: The company's current ratio deteriorated and stood at 50.4x during FY23, from 100.1x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

• Profitability Ratios

Return on Equity (ROE): The ROE for the company declined and down at 1.3% during FY23, from 1.7% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

Return on Capital Employed (ROCE): The ROCE for the company declined and down at 1.3% during FY23, from 1.7% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

Return on Assets (ROA): The ROA of the company declined and down at 1.3% during FY23, from 1.7% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending		12 Mar-22*	12 Mar-23*
Current ratio	x	100.1	50.4
Debtors’ Days	Days	0	0
Interest coverage	x	0.0	0.0
Debt to equity ratio	x	0.0	0.0
Return on assets	%	1.7	1.3
Return on equity	%	1.7	1.3
Return on capital employed	%	1.7	1.3

To see how UNIPHOS ENT has performed over the last 5 years, please visit here.

UNIPHOS ENT Share Price Performance

Over the last one year, UNIPHOS ENT share price has moved up from Rs 132.4 to Rs 153.9, registering a gain of Rs 21.6 or around 16.3%.

Overall, the S&P BSE SENSEX is up 1.8% over the year.

(To know more, check out historical annual results for UNIPHOS ENT and quarterly results for UNIPHOS ENT)